Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MARIEJANE BRAZA

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1144467515
CMS profile
1022411
Location
VERO BEACH, FL

General Payments · PY2019–2022

$591.50

  • Reported across 33 records
  • CMS publication 2026-06-30

Latest program year · PY2022

$275.88

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $275.88 15

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
ViiV Healthcare Company $134.00 7
Merck Sharp & Dohme Corporation $49.12 3
Gilead Sciences, Inc. $34.52 2
ABBVIE INC. $29.50 1
Janssen Biotech, Inc. $28.74 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $103.74 6
PY2020 $132.72 7
PY2021 $79.16 5
PY2022 $275.88 15

Payment records · PY2022 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2022 201920202021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $29.50 09/14/2022 Food and Beverage Undisputed 06/30/2026 890653821 CMS
Gilead Sciences, Inc. $18.25 04/18/2022 Food and Beverage Undisputed 06/30/2026 929585473 CMS
Gilead Sciences, Inc. $16.27 07/14/2022 Food and Beverage Undisputed 06/30/2026 929585471 CMS
Janssen Biotech, Inc. $12.77 11/10/2022 Food and Beverage Undisputed 06/30/2026 886670075 CMS
Janssen Biotech, Inc. $15.97 12/08/2022 Food and Beverage Undisputed 06/30/2026 886670081 CMS
Merck Sharp & Dohme LLC $15.89 03/29/2022 Food and Beverage Undisputed 06/30/2026 944146747 CMS
Merck Sharp & Dohme LLC $20.36 04/27/2022 Food and Beverage Undisputed 06/30/2026 944368547 CMS
Merck Sharp & Dohme LLC $12.87 10/20/2022 Food and Beverage Undisputed 06/30/2026 944237745 CMS
ViiV Healthcare Company $18.33 03/30/2022 Food and Beverage Undisputed 06/30/2026 944083441 CMS
ViiV Healthcare Company $17.77 05/18/2022 Food and Beverage Undisputed 06/30/2026 944083453 CMS
ViiV Healthcare Company $18.02 05/25/2022 Food and Beverage Undisputed 06/30/2026 944083461 CMS
ViiV Healthcare Company $19.41 07/25/2022 Food and Beverage Undisputed 06/30/2026 944083449 CMS
ViiV Healthcare Company $22.12 10/26/2022 Food and Beverage Undisputed 06/30/2026 944083437 CMS
ViiV Healthcare Company $19.65 11/16/2022 Food and Beverage Undisputed 06/30/2026 944083445 CMS
ViiV Healthcare Company $18.70 11/30/2022 Food and Beverage Undisputed 06/30/2026 944083457 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.